More importantly, the Kaplan–Meier survival analysis revealed that TRPS1 mutation closely correlates with poor disease-free survival (DFS) (P = 0.0019) and worse overall survival (OS) (P = 0.039), highlighting its prognostic relevance in CRC patients (Fig. 6l). The gene discussed is TRPS1; the disease is colorectal carcinoma.